clinical trials

Latest Headlines

Latest Headlines

Nanoparticles made from grapefruit lipids deliver drugs safely

Using lipids derived from grapefruits, researchers at the University of Louisville have created nanoparticles for drug delivery that are less toxic to both people and the environment and may offer a less expensive alternative to synthetic materials.

Elixir bolsters recent CE mark with successful pivotal trial

Less than a week after securing a CE mark for its DESolve drug-eluting stent, Elixir Medical reported successful results in a pivotal trial of the same device, which should reach the market by the end of this year.

Novaliq pulls in $18.1M for ocular delivery tech

Novaliq's drug delivery platform that helps poorly soluble drugs dissolve more easily helped the company pull in a sizable funding round, which in turn could push its lead dry eye product into Phase I trials.

New trial search engine steps into congested market

Another clinical trial search engine rolled out this week with talk of making it easier for patients to find studies, and vice versa. But the website, MyClinicalTrialLocator, finds itself in an increasingly congested market filled with CROs, in-house Big Pharma platforms and niche players.

Microsoft developing database to diversify clinical trials

Microsoft is applying its database know-how to the problem of the lack of minority participation in clinical trials. The tech giant is turning data gathered by the National Minority Quality Forum into a searchable national archive to support the diversification of trials.

GSK ups the ante for trial transparency

GlaxoSmithKline has long been the Big Pharma standard-bearer for open clinical trial data, and now the drugmaker has thrown its support behind the AllTrials campaign, a U.K. initiative to register and publicize all studies.

Indian clinical trials: Private group steps in to increase transparency

As India's government churns over the idea of tightening clinical trial regulations, a private industry group is entering the fold and launching a committee designed to improve transparency.

Endosense eyes FDA nod with ablation trial

Fresh off raising $40.3 million in venture cash, Endosense has treated its first American patient in a study of its cardiac catheter ablation device, and the company is amassing data to support an FDA application.

Startup hops out of incubator with cloud software for pharma

Philadelphia has hatched a startup with ambitious goals for improving how investigators and companies keep in touch during clinical trials. With customers and a third version of its web-based software out the door, myClin has grown out of shared office space in Old City and moved to its own office in a nearby location, MedCity News reported.

Indian Supreme Court wants answers on clinical trials

Earlier this month, India's Supreme Court bemoaned that unregulated clinical trials were "causing havoc" in the country, demanding that the Central Drugs Standard Control Organization explain how it intends to fix the situation. Now the regulator has until the end of the mont to come up with some answers.